FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
The FDA has expanded the indications for Johnson & Johnson MedTech’s Impella CP and Impella 5.5 with SmartAssist heart pumps, granting premarket approval for use in specific pediatric patients with symptomatic acute decompensated heart failure and cardiogenic shock.